ClearOne, Inc. — Q2 2014 Form 10-Q Summary
Business context and reporting period
ClearOne designs and sells conferencing, collaboration, streaming and digital-signage solutions for audio and visual communications. This unaudited Form 10-Q covers the three and six months ended June 30, 2014, compared with the corresponding 2013 periods.
During the period, ClearOne acquired Sabine, Inc., a professional wireless microphone business, and the Spontania business of Dialcom Networks, S.L., a cloud-based video collaboration technology business.
Financial performance and position
| Metric | Three months ended June 30 | Six months ended June 30 |
|---|---|---|
| Revenue | $14.1 million vs. $11.7 million | $26.8 million vs. $23.0 million |
| Gross profit | $8.1 million vs. $6.9 million | $15.8 million vs. $13.9 million |
| Gross margin | 57% vs. 59% | 59% vs. 60% |
| Operating income | $1.1 million vs. $1.5 million | $1.9 million vs. $2.6 million |
| Net income | $0.9 million vs. $1.0 million | $1.4 million vs. $1.8 million |
| Diluted EPS | $0.10 vs. $0.11 | $0.15 vs. $0.19 |
Revenue growth reflected stronger demand, particularly in North America and EMEA, increased professional audio and microphone sales, and acquired products. Unified communications and video-product revenue declined. Sales and marketing, research and development, and general and administrative expenses increased due to acquisitions, higher headcount, commissions, trade shows, product development, amortization and acquisition-related costs.
Cash provided by operating activities was $2.8 million in the first six months of 2014, compared with cash used of $12.6 million in the 2013 period. The prior-year period included a substantial income-tax payment related to arbitration settlement proceeds.
| Liquidity and capital resources | June 30, 2014 | December 31, 2013 |
|---|---|---|
| Cash and cash equivalents | $6.3 million | $17.2 million |
| Marketable securities | $26.0 million | $25.5 million |
| Cash, cash equivalents and marketable securities | Approximately $32.3 million | Approximately $42.7 million |
| Working capital | $30.3 million | $39.4 million |
| Total liabilities | $13.2 million | $10.7 million |
The filing does not identify outstanding borrowings or debt financing. Investing cash outflows of $13.9 million primarily comprised approximately $8.0 million for Sabine, $5.1 million for Spontania, equipment purchases and patent purchases. Financing activities provided $0.1 million, including $1.3 million from option exercises offset by $1.2 million of stock repurchases.
Material changes versus the prior comparable period
- Quarterly revenue increased 21%; six-month revenue increased 17%.
- Quarterly and year-to-date gross profit increased, but gross margins declined by approximately two percentage points and one percentage point, respectively.
- Operating income declined 25% for the quarter and 26% year to date, primarily because operating expenses grew faster than gross profit.
- Net income declined 11% for the quarter and 20% year to date.
- Sales and marketing expense increased 43% for the quarter and 31% year to date; research and development expense increased 26% and 23%, respectively.
- Deferred product revenue increased to $5.2 million from $4.2 million at year-end, while distributor channel inventory increased to $1.8 million from $1.5 million.
- Goodwill increased to $12.5 million from $3.5 million and net intangible assets increased to $9.0 million from $3.7 million, principally due to the acquisitions.
Guidance, outlook, risks and unusual items
Management expects continued revenue growth from the acquisitions and professional audio products, but states that near-term revenue and profit growth depend on global economic conditions and market penetration of new and acquired products. No quantitative earnings or revenue guidance was provided.
The acquisitions involved provisional purchase-price allocations that may change materially during the measurement period. Sabine consideration totaled $10.5 million, including $8.2 million cash, $1.7 million in stock and estimated contingent consideration of $0.7 million. Spontania consideration was approximately $5.1 million in cash. Acquisition-related expenses were $0.4 million.
Key disclosed risks include product recalls and liability claims, intellectual-property disputes, supplier disruptions, customer and product concentration, competition, product obsolescence, inventory valuation, foreign-currency fluctuations, dependence on market acceptance and execution of new products, and the ability to integrate acquisitions. The company also reported continued high legal expenses and an updated former-officer indemnification matter; a settlement with the former officer was reached on August 5, 2014.
The company recorded $0.4 million of inventory valuation and obsolescence charges in the first six months of 2014. The forecasted effective tax rate was 34.7%, and the six-month effective rate was 30.0% after a $0.1 million discrete tax benefit. Management concluded that disclosure controls were effective as of June 30, 2014, with no material change in internal control over financial reporting.
Important facts for investors to verify
- Whether acquired Sabine and Spontania operations achieve expected revenue growth, synergies and profitability; reported post-acquisition results included losses of $0.1 million for Sabine and $0.2 million for Spontania.
- The final purchase-price allocations, contingent consideration and potential changes to goodwill and intangible assets.
- The sustainability of revenue growth amid declining unified communications and video-product revenue.
- Whether gross-margin pressure and substantially higher operating expenses moderate future earnings.
- Cash use for acquisitions, repurchases and potential additional acquisitions, and the resulting decline in cash and working capital.
- Inventory levels, channel inventory and deferred revenue, including the accuracy of distributor sell-through reports.
- Pending or future legal costs and outcomes, intellectual-property exposure, supplier risks and product-obsolescence risks.